The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients ; volume:136 ; number:15-16 ; day:17 ; month:6 ; year:2024 ; pages:458-464 ; date:8.2024
Wiener klinische Wochenschrift ; 136, Heft 15-16 (17.6.2024), 458-464, 8.2024
- Urheber
-
Platzer, Moritz
Totschnig, David
Karolyi, Mario
Clodi-Seitz, Tamara
Wenisch, Christoph
Zoufaly, Alexander
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00508-024-02377-7
- URN
-
urn:nbn:de:101:1-2411022119030.964113869212
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Platzer, Moritz
- Totschnig, David
- Karolyi, Mario
- Clodi-Seitz, Tamara
- Wenisch, Christoph
- Zoufaly, Alexander
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study
Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database
The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study
Remdesivir: A Review in COVID-19
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned
Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V
Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment
Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study
Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database
The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study
Remdesivir: A Review in COVID-19
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned
Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V
Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment
Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study
Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database
The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study
Remdesivir: A Review in COVID-19
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned
Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V